Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jul;60(1):105-106.
doi: 10.1111/apt.18044. Epub 2024 May 27.

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis

Xiaoyan Ao  1 , Yu Zeng  1 , Xianglin Wang  1 , Xiaoli Fan  1
Affiliations
Comment

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis

Xiaoyan Ao et al. Aliment Pharmacol Ther. 2024 Jul.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Hofer BS, Burghart L, Halilbasic E, Simbrunner B, Petrenko O, Mandorfer M, et al. Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Aliment Pharmacol Ther. 2024;59:962–972.
    1. European Association for the Study of the Liver. The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145–172.
    1. Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, et al. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo‐controlled study. Hepatology. 2023;78:397–415.
    1. Murillo Perez CF, Ioannou S, Hassanally I, Trivedi PJ, Corpechot C, van der Meer AJ, et al. Optimizing therapy in primary biliary cholangitis: alkaline phosphatase at six months identifies one‐year non‐responders and predicts survival. Liver Int. 2023;43:1497–1506.
    1. Ding D, Xuan G, Hu Y, Yu J, Liu Y, Guo G, et al. Immunoglobulin M: a neglected serum biomarker in treatment‐naive primary biliary cholangitis with normal alkaline phosphatase. Hepatol Commun. 2022;6:1403–1412.

MeSH terms

LinkOut - more resources